My research focus in Dr. Ralph Tripp's Laboratory at the University of Georgia is in respiratory syncytial virus (RSV) vaccine development using a rational reverse vaccinology, structure based approach for a robust RSV-G vaccine. Thus, my studies also include understanding the RSV-G:host interaction, namely through the RSV-G:CX3CR1 as the RSV-G is a functional Fractalkine mimic, and the immunopathology of RSV. We collaborate with experts in academia and industry to design, develop and evaluate potential new vaccine candidates to solve the global challenge of RSV morbidity and mortality.
- Host Pathogen Interaction
- Vaccine and Therapeutic Development
- Biodefense & High-Consequence Pathogens
- Virginia Tech, BS 2015